LEADER 02519nam  2200493   450 
001 9910717345703321
005 20221104205458.0
035   $a(CKB)2670000000429444
035   $a(NjHacI)992670000000429444
035   $a(OCoLC)793073726$z(OCoLC)1117847271
035   $a(EXLCZ)992670000000429444
100   $a20221104d2011      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTreatment of anemia in patients with heart disease $ea systematic review /$fDevan Kansagara [and four others]
210  1$aWashington, DC :$cDepartment of Veterans Affairs,$d2011.
215   $a1 online resource (iii, 78 pages) $cillustrations
225 1 $aEvidence-based Synthesis Program
300   $a"Evidence-based synthesis program."
300   $a"October 2011."
320   $aIncludes bibliographical references.
330 3 $aAnemia is very common in congestive heart failure (CHF) and coronary heart disease (CHD) patients. Anemia in CHF and CHD patients is associated with poorer outcomes, including an increased risk of hospitalization, decreased exercise capacity, and poor quality of life. Despite the association with poorer outcomes, it is unclear whether treating anemia or iron deficiency will improve outcomes. Anemia treatment strategies in heart failure and CHD patients include erythropoiesis-stimulating agents (ESAs) and red blood cell transfusions. Iron replacement in iron deficient patients with or without anemia has also been investigated. The objective of this evidence review is to evaluate the balance of benefit and harms of these treatments.
410  0$aEvidence-based synthesis program (Series)
517   $aTreatment of anemia in patients with heart disease
606   $aAnemia
606   $aHeart$xDiseases$xDiagnosis
607   $aUnited States$2fast
608   $aTechnical reports.$2lcgft
615  0$aAnemia.
615  0$aHeart$xDiseases$xDiagnosis.
676   $a616.152
700   $aKansagara$b Devan$01351781
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
712 02$aPortland VA Medical Center.$bEvidence-based Synthesis Program Center.
712 02$aEvidence-based Synthesis Program (U.S.)
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717345703321
996   $aTreatment of anemia in patients with heart disease$93275653
997   $aUNINA